EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon

Rosa Cristina Caldas Belota, Jean de Melo Silva, Eduardo Luiz do Nascimento, Cláudia Maria de Moura Abrahim, Márcia Costa Castilho, José Pereira Moura Neto iD, Sérgio Roberto Lopes Albuquerque

Viruses · 2024

DOI: 10.3390/v16101632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Rosa Cristina Caldas Belota und 6 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Hematologia e Hemoterapia do Amazonas (PPGH/UEA/HEMOAM), Manaus 69050-001, Amazonas, Brazil. Hauptthemen laut MEDLINE: Blood Donors, Hepatitis B virus, Hepatitis B, Viral Load. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado do Amazonas, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B is an infectious disease of worldwide importance and of great interest to transfusion medicine. The Amazon region has areas of high endemicity, outlining a worrying scenario for transfusion and epidemiological safety.

Objective

To analyze the profiles of serological and molecular markers for HBV of blood donors from HEMOAM.

Methods

Blood donors with different patterns of reactivity in serological and molecular screening for HBV were tested for viral load by the qPCR method at the reference center for liver diseases in the state of Amazonas.

Results

A total of 230,591 donors were tested, with 3104 (1.34%) found reactive for HBV and 2790 (89.9%) found reactive for isolated anti-HBc. Viral load was not detected in 100% of donors reactive only to HBsAg, while 100% of donors with positive anti-HBc and positive HBsAg or HBV NAT demonstrated a detectable viral load. We also detected one case of occult hepatitis B (0.03%) only with reactive HBV NAT and five donors (0.2%) with positive anti-HBc and HBV NAT.

Conclusions

With this result, the great importance of the anti-HBc test for the unsuitability of blood donors was verified, as well as the fundamental introduction of the HBV NAT test in screening for hepatitis B in Brazilian blood banks, as this was the only way to detect the viral infection burden in asymptomatic donors who previously would not be treated, which contributed to the maintenance of the endemicity of hepatitis B in the Brazilian Amazon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsHepatitis B virusHepatitis BViral LoadHepatitis B Surface AntigensHepatitis B AntibodiesHumansBrazilMaleFemaleAdultMiddle AgedYoung AdultMass ScreeningAdolescentDNA, ViralBlood Safety

Stichwörter der Autor:innen

blood transfusionepidemiologyhepatitis Bsafety transfusion

Substanzen

Hepatitis B Surface AntigensHepatitis B AntibodiesDNA, Viral

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Hematologia e Hemoterapia do Amazonas (PPGH/UEA/HEMOAM), Manaus 69050-001, Amazonas, Brazil.
  • Programa de Pós-Graduação em Imunologia Básica e Aplicada (PPGIBA/UFAM), Manaus 69080-900, Amazonas, Brazil.
  • Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus 69036-110, Amazonas, Brazil.
  • Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF/UFAM), Manaus 69080-900, Amazonas, Brazil.

ORCID-Profile: José Pereira Moura Neto

Förderung

  • Fundação de Amparo à Pesquisa do Estado do Amazonas
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM)-Pró-Estado Program
  • POSGRAD Program

Zitieren

APA

Belota, R. C. C., Silva, J. M., Nascimento, E. L. D., Abrahim, C. M. M., Castilho, M. C., Moura Neto, J. P., & Albuquerque, S. R. L. (2024). Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon. Viruses. https://doi.org/10.3390/v16101632

Vancouver

Belota RCC, Silva JM, Nascimento ELD, Abrahim CMM, Castilho MC, Moura Neto JP, et al. Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon. Viruses. 2024. doi:10.3390/v16101632

BibTeX
@article{Belota2024,
  author = {Belota, Rosa Cristina Caldas and Silva, Jean de Melo and Nascimento, Eduardo Luiz do and Abrahim, Cláudia Maria de Moura and Castilho, Márcia Costa and Moura Neto, José Pereira and Albuquerque, Sérgio Roberto Lopes},
  title = {Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101632}
}
Kostenlos starten →